Despite the fact that fibrin is useful for the body system, excess fibrin has been found to be responsible for scar tissue, thrombus formation and inflammation with its associated pain. Our body system can not handle excessive fibrin. Scientific studies have shown that excess fibrin weakens the body structure by not leaving enough space for epithelial tissue to grow through the fibrin matrix, restricting the range of joint and muscle motion and reducing the internal organs size and function over time. Nattokinase is one of the essential Fibrinolytic enzymes, which act to break down excess fibrin in the body. These enzymes fight inflammation, fibrosis (scar tissues), and viruses; modulate the immune system; and cleanse the blood. Excess fibrin is responsible for the spider web of scar tissue across the inside of blood vessels that forms the matrix upon which arterial plaque is laid down and can also form in the kidneys contributing to high blood pressure, and in the brain causing poor brain function and senility. Similarly, the pain and suffering associated with fibromyalgia is caused by an overgrowth of fibrin in the muscles, commonly known as fibrosis.
Fibrinolytic enzymes dissolve the excess fibrin in the muscles providing increased flexibility and blessed relief of pain. They are systemic enzymes that eat away the excess fibrin that forms scar tissue, adhesions, and growths. As we get older, these enzymes decrease and wounds leave bigger scars. The conditions like uterine fibroids, fibrocystic breasts, and the hardening, shrinking, and decreased function of aging organs are a result of an accumulation of fibrin in the body due to a depletion of fibrinolytic enzymes. Nattokinase has been discovered and shows great potential in providing support for hypercoagulative states and in supporting the activation of many of the bodies 3,000 endogenous enzymes. It is derived from fermented soy and the bacteria Bacillus natto. Nattokinase may prove to be a defibrinogenating enzyme that drastically decreases blood viscosity. Decreasing blood viscosity strikes at the root of arteriosclerosis and atherosclerosis as well as hypertension, peripheral vascular disease and congestive heart failure. The fibrinolytic activity of Nattokinase resolves the active process of atherosclerosis and lyses thrombi. It produces a prolonged action as it prevents coagulation of blood and it dissolves existing thrombus.
References:
N.Calvino, Dr. (2007). Nattokinase: The Enzyme of Enzymes. Retrieved on July 19, 2007 from http://www.willner.com/article.aspx?artid=88
R. Holsworth (2005). Nattokinase, Enzyme Treatment for Chronic Inflammation, Hypercoagulability, and Crosslinked Fibrin. Retrieved on July 18, 2007 from http://smartlifeforum.org/2005/08/newsletter.html
